Publications

• What Is the Expected Clearance of Methotrexate? A Therapeutic Drug Monitoring Reference Guide for High-Dose Methotrexate Use in Pediatric Malignancies.
  Pediatr Blood Cancer Volume: 72 Page(s): e31744
  07/01/2025 Authors: Taylor ZL; Miller TP; Board SG; Poweleit EA; Chavana A; Weisnicht A; Brown AL; Bernhardt MB; Schafer ES; O'Brien MM
• Nivolumab-AVD Versus Brentuximab Vedotin-AVD in Older Patients With Advanced-Stage Classic Hodgkin Lymphoma Enrolled on S1826.
  J Clin Oncol Page(s): JCO2500204
  06/16/2025 Authors: Rutherford SC; Li H; Herrera AF; LeBlanc M; Ahmed S; Davison K; Parsons SK; Unger JM; Perry AM; Casulo C
• Adolescent and Young Adult Oncology in the United States in 2025: Finding Its Place in the Oncology World Part 2 of 2.
  J Pediatr Hematol Oncol
  06/09/2025 Authors: Shaw PH; Castellino SM; Guerrettaz R; Yeager N; Zebrack B; Brandon R; Bleyer A
• Disparities in Clinical Trial Participation in Children and Adolescent Patients With a Hematologic Malignancy.
  Pediatr Blood Cancer Volume: 72 Page(s): e31641
  06/01/2025 Authors: Monroe C; Muiz JP; Leong T; Lewis RW; Castellino SM
• Immune-aging at diagnosis determines T-cell recovery in childhood leukemia survivors.
  NPJ Aging Volume: 11 Page(s): 39
  05/23/2025 Authors: Dhodapkar KM; Castellino S; Kapadia S; Azeem MI; Horvat A; Lawrence T; DeRyckere D; Dhodapkar MV
• Identification of leukemia-enriched signature through the development of a comprehensive pediatric single-cell atlas.
  Nat Commun Volume: 16 Page(s): 4114
  05/02/2025 Authors: Mumme HL; Huang C; Ohlstrom D; Bakhtiari M; Raikar SS; DeRyckere D; Qayed M; Castellino SM; Wechsler DS; Porter CC
• PET Response and Outcome in Low-Risk Nodular Lymphocyte-Predominant Hodgkin Lymphoma: Children's Oncology Group Study AHOD03P1.
  Pediatr Blood Cancer Volume: 72 Page(s): e31606
  05/01/2025 Authors: Marks LJ; Wu Y; McCarten KM; Renfro LA; Pei Q; Kelly KM; Schwartz CL; Castellino SM; Appel BE
• A framework-based guide for adapting and implementing primary care-based pediatric interventions to the pediatric oncology setting: HPV PROTECT as an exemplar.
  Cancer Volume: 131 Page(s): e35857
  05/01/2025 Authors: Klosky JL; Cherven B; Gilkey MB; Aye J; Castellino SM; Gramatges MM; Lindemulder S; Russell TB; Turcotte LM; Campos Gonzlez PD
• Body Composition at Diagnosis and Early Response in Pediatric Hodgkin Lymphoma.
  Cancer Epidemiol Biomarkers Prev Volume: 34 Page(s): 560 - 567
  04/03/2025 Authors: Wadhwa A; Dai C; Kessel S; Richman JS; Shen W; Kahn JM; Castellino SM; Kelly KM; Friedman DL; Bhatia S
• Protocol-Stipulated Dose Modification to Manage Chemotherapy-Induced Peripheral Neuropathy in Children, Adolescents, and Young Adults With High-Risk Hodgkin Lymphoma.
  JCO Oncol Pract Volume: 21 Page(s): 526 - 534
  04/01/2025 Authors: Heneghan MB; Parsons SK; Keller FG; Renfro LA; Pei Q; Rodday AM; Wu Y; Punnett A; Belsky JA; Henderson TO
• Extracellular vesicles from the lung pro-thrombotic niche drive cancer-associated thrombosis and metastasis via integrin beta 2.
  Cell Volume: 188 Page(s): 1642 - 1661.e24
  03/20/2025 Authors: Lucotti S; Ogitani Y; Kenific CM; Geri J; Kim YH; Gu J; Balaji U; Bojmar L; Shaashua L; Song Y
• Association Between Medicaid Coverage Continuity and Survival in Patients With Newly Diagnosed Pediatric and Adolescent Cancers.
  JCO Oncol Pract Volume: 21 Page(s): 380 - 390
  03/01/2025 Authors: Hu X; Castellino SM; Kirchhoff AC; Williamson Lewis RS; DeGroote NP; Cornwell P; Mertens AC; Lipscomb J; Ji X
• Transplant-Free Salvage Therapy for Low-Risk Relapsed Pediatric Hodgkin Lymphoma: A Nonrandomized Clinical Trial.
  JAMA Oncol Volume: 11 Page(s): 340 - 342
  03/01/2025 Authors: Hoppe BS; Milgrom SA; Renfro LA; Wu Y; Schwartz CL; Constine LS; McCarten KM; Kelly KM; Hodgson D; Castellino SM
• Health insurance continuity and mortality in children, adolescents, and young adults with blood cancer.
  J Natl Cancer Inst Volume: 117 Page(s): 344 - 354
  02/01/2025 Authors: Ji X; Zhang XE; Yabroff KR; Stock W; Cornwell P; Bai S; Mertens AC; Lipscomb J; Castellino SM
• Medicaid coverage continuity is associated with lymphoma stage among children and adolescents/young adults.
  Blood Adv Volume: 9 Page(s): 280 - 290
  01/28/2025 Authors: Zhang XE; Castellino SM; Yabroff KR; Stock W; Cornwell P; Bai S; Mertens AC; Lipscomb J; Ji X
• The lasting impact of the ACA: how Medicaid expansion reduces outcome disparities in AYAs with leukemia and lymphoma.
  Hematology Am Soc Hematol Educ Program Volume: 2024 Page(s): 10 - 19
  12/06/2024 Authors: Hu X; Castellino SM; Ji X
• What Is Childhood Lymphoma?
  JAMA Pediatr Volume: 178 Page(s): 1234
  11/01/2024 Authors: Heneghan MB; Castellino SM; Thompson LA
• Association of Medicaid Expansion With Timely Receipt of Treatment and Survival Among Patients With HR-Negative, HER2-Positive Breast Cancer.
  J Natl Compr Canc Netw Volume: 22 Page(s): 593 - 599
  10/23/2024 Authors: Shi KS; Ji X; Jiang C; Ruddy KJ; Castellino SM; Yabroff KR; Han X
• Nivolumab+AVD in Advanced-Stage Classic Hodgkin's Lymphoma.
  N Engl J Med Volume: 391 Page(s): 1379 - 1389
  10/17/2024 Authors: Herrera AF; LeBlanc M; Castellino SM; Li H; Rutherford SC; Evens AM; Davison K; Punnett A; Parsons SK; Ahmed S
• Automatic Quantification of Serial PET/CT Images for Pediatric Hodgkin Lymphoma Patients Using a Longitudinally-Aware Segmentation Network.
  ArXiv
  10/01/2024 Authors: Tie X; Shin M; Lee C; Perlman SB; Huemann Z; Weisman AJ; Castellino SM; Kelly KM; McCarten KM; Alazraki AL
• Toxicity profile of high-dose methotrexate in young children with central nervous system tumors.
  Pediatr Blood Cancer Volume: 71 Page(s): e31213
  10/01/2024 Authors: Chavana AN; Taylor ZL; DeGroote N; Lindsay HB; Sauer HE; Mason EJ; Schafer ES; Miller TP; Castellino SM; Pommert L
• Longitudinal Health-Related Quality of Life Among Patients With High-Risk Pediatric Hodgkin Lymphoma Treated on the Children's Oncology Group AHOD 1331 Study.
  J Clin Oncol Volume: 42 Page(s): 3330 - 3338
  10/01/2024 Authors: Williams AM; Rodday AM; Pei Q; Henderson TO; Keller FG; Punnett A; Kelly KM; Castellino SM; Parsons SK
• Hodgkin lymphoma involving the extra-axial CNS: an AHOD1331, PHL-C1, and PHL-C2 report from the COG and EuroNet-PHL.
  Blood Adv Volume: 8 Page(s): 4856 - 4865
  09/24/2024 Authors: Pabari R; McCarten K; Flerlage J; Lai H; Mauz-Krholz C; Dieckmann K; Palese M; Kaste S; Castellino SM; Kelly KM
• A systematic literature review of clinical evidence and treatment burden in newly diagnosed high-risk pediatric patients with classical Hodgkin lymphoma.
  Pediatr Blood Cancer Volume: 71 Page(s): e31027
  08/01/2024 Authors: Flerlage JE; Waters-Banker C; Fanale M; Beckerman R; Castellino SM; Liu N
• Exposure-Response and Subgroup Analyses to Support Body Weight-Based Dosing of Brentuximab Vedotin in Children and Young Adults with Newly Diagnosed High-risk Classical Hodgkin Lymphoma.
  Clin Cancer Res Volume: 30 Page(s): 3273 - 3281
  08/01/2024 Authors: Zhang Z; Zhang D; Guo W; Fenton K; Narayanan S; Jain S; Jiang J; Castellino SM; Kelly KM; Cole PD
• HLH and Recurrent EBV Lymphoma as the presenting manifestation of MAGT1 Deficiency: A Systematic Review of the Expanding Disease Spectrum.
  J Clin Immunol Volume: 44 Page(s): 153
  06/19/2024 Authors: Golloshi K; Mitchell W; Kumar D; Malik S; Parikh S; Aljudi AA; Castellino SM; Chandrakasan S
• Liver Late Effects in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review.
  Int J Radiat Oncol Biol Phys Volume: 119 Page(s): 575 - 587
  06/01/2024 Authors: Hall MD; Howell RM; Jackson A; Owens CA; Hernandez S; Castellino SM; Ronckers CM; Constine LS; Bradley JA
• Pediatric and Adolescent Hodgkin Lymphoma: Paving the Way for Standards of Care and Shared Decision Making.
  Am Soc Clin Oncol Educ Book Volume: 44 Page(s): e432420
  06/01/2024 Authors: Kahn JM; Mauz-Korholz C; Hernandez T; Milgrom SA; Castellino SM
• Accelerating pediatric Hodgkin lymphoma research: the Hodgkin Lymphoma Data Collaboration (NODAL).
  J Natl Cancer Inst Volume: 116 Page(s): 642 - 646
  05/08/2024 Authors: Wyatt KD; Birz S; Castellino SM; Henderson TO; Lucas JT; Pei Q; Zhou Y; Volchenboum SL; Furner B; Watkins M
• Personalized Impression Generation for PET Reports Using Large Language Models.
  J Imaging Inform Med Volume: 37 Page(s): 471 - 488
  04/01/2024 Authors: Tie X; Shin M; Pirasteh A; Ibrahim N; Huemann Z; Castellino SM; Kelly KM; Garrett J; Hu J; Cho SY
• Missing the mark? Exploratory analysis of the 10-year-old cutoff as an independent marker of high-risk disease in pediatric B-ALL.
  Pediatr Blood Cancer Volume: 71 Page(s): e30825
  03/01/2024 Authors: George PE; DeGroote NP; Henderson M; Jordan K; Ziworitin-Ogola C; Castellino SM; Miller TP
• Author Correction: A joint international consensus statement for measuring quality of survival for patients with childhood cancer.
  Nat Med Volume: 30 Page(s): 605
  02/01/2024 Authors: van Kalsbeek RJ; Hudson MM; Mulder RL; Ehrhardt M; Green DM; Mulrooney DA; Hakkert J; den Hartogh J; Nijenhuis A; van Santen HM
• Late Cardiac Toxic Effects Associated With Treatment Protocols for Hodgkin Lymphoma in Children.
  JAMA Netw Open Volume: 7 Page(s): e2351062
  01/02/2024 Authors: Lo AC; Liu A; Liu Q; Yasui Y; Castellino SM; Kelly KM; Hererra AF; Friedberg JW; Friedman DL; Schwartz CL
• Distinct Hodgkin lymphoma subtypes defined by noninvasive genomic profiling.
  Nature Volume: 625 Page(s): 778 - 787
  01/01/2024 Authors: Alig SK; Shahrokh Esfahani M; Garofalo A; Li MY; Rossi C; Flerlage T; Flerlage JE; Adams R; Binkley MS; Shukla N
• Proceedings and Abstracts From the Fifth International Symposium on Childhood, Adolescent, and Young Adult Hodgkin Lymphoma (ISCAYAHL) Meeting.
  J Pediatr Hematol Oncol Page(s): e1 - e43
  12/18/2023 Authors: Flerlage JE; Palese M; Mauz-Koerholz C; Castellino SM
• Utilization of cardiac tests in anthracycline-treated cancer survivors differs between young adults and children: A claims-based analysis.
  Cancer Med Volume: 12 Page(s): 22056 - 22061
  12/01/2023 Authors: Ji X; Hu X; Lipscomb J; Chow EJ; Mertens AC; Castellino SM
• Performance of the FACT-GOG-Ntx to assess chemotherapy-induced peripheral neuropathy (CIPN) in pediatric high risk Hodgkin lymphoma: report from the Children's Oncology Group AHOD 1331 study.
  J Patient Rep Outcomes Volume: 7 Page(s): 113
  11/10/2023 Authors: Parsons SK; Rodday AM; Pei Q; Keller FG; Wu Y; Henderson TO; Cella D; Kelly KM; Castellino SM
• Clinical covariates that improve the description of high dose methotrexate pharmacokinetics in a diverse population to inform MTXPK.org.
  Clin Transl Sci Volume: 16 Page(s): 2130 - 2143
  11/01/2023 Authors: Taylor ZL; Miller TP; Poweleit EA; DeGroote NP; Pommert L; Awoniyi O; Board SG; Ugboh N; Joshi V; Ambrosino N
• Automatic Personalized Impression Generation for PET Reports Using Large Language Models.
  ArXiv
  10/17/2023 Authors: Tie X; Shin M; Pirasteh A; Ibrahim N; Huemann Z; Castellino SM; Kelly KM; Garrett J; Hu J; Cho SY
• Single-cell RNA sequencing distinctly characterizes the wide heterogeneity in pediatric mixed phenotype acute leukemia.
  Genome Med Volume: 15 Page(s): 83
  10/16/2023 Authors: Mumme HL; Raikar SS; Bhasin SS; Thomas BE; Lawrence T; Weinzierl EP; Pang Y; DeRyckere D; Gawad C; Wechsler DS
• Single-cell analysis reveals altered tumor microenvironments of relapse- and remission-associated pediatric acute myeloid leukemia.
  Nat Commun Volume: 14 Page(s): 6209
  10/05/2023 Authors: Mumme H; Thomas BE; Bhasin SS; Krishnan U; Dwivedi B; Perumalla P; Sarkar D; Ulukaya GB; Sabnis HS; Park SI
• Radiation Therapy Use in Refractory and Relapsed Adolescent and Young Adult Hodgkin Lymphoma: A Report from the Children's Oncology Group.
  Int J Radiat Oncol Biol Phys Volume: 117 Page(s): 400 - 403
  10/01/2023 Authors: Mailhot Vega RB; Harker-Murray PD; Forlenza CJ; Cole P; Kelly KM; Milgrom SA; Parikh RR; Hodgson DC; Castellino SM; Kahn J
• Children's Oncology Group's 2023 blueprint for research: Hodgkin lymphoma.
  Pediatr Blood Cancer Volume: 70 Suppl 6 Page(s): e30580
  09/01/2023 Authors: Castellino SM; Giulino-Roth L; Harker-Murray P; Kahn JM; Forlenza C; Cho S; Hoppe B; Parsons SK; Kelly KM; COG Hodgkin Lymphoma Committee
• Medicaid expansion is associated with treatment receipt, timeliness, and outcomes among young adults with breast cancer.
  JNCI Cancer Spectr Volume: 7
  08/31/2023 Authors: Ji X; Shi KS; Ruddy KJ; Zhao J; Mertens AC; Yabroff KR; Castellino SM; Han X
• Pediatric T-cell acute lymphoblastic leukemia blast signature and MRD associated immune environment changes defined by single cell transcriptomics analysis.
  Sci Rep Volume: 13 Page(s): 12556
  08/02/2023 Authors: Bhasin SS; Thomas BE; Summers RJ; Sarkar D; Mumme H; Pilcher W; Emam M; Raikar SS; Park SI; Castellino SM
• Importance of Central Imaging Review in a Pediatric Hodgkin Lymphoma Trial Using Positron Emission Tomography Response Adapted Radiation Therapy.
  Int J Radiat Oncol Biol Phys Volume: 116 Page(s): 1025 - 1030
  08/01/2023 Authors: Hoppe BS; McCarten KM; Pei Q; Kessel S; Alazraki A; Mhlanga JC; Lai HA; Eutsler E; Hodgson DC; Roberts KB
• Siglec-15 Promotes Evasion of Adaptive Immunity in B-cell Acute Lymphoblastic Leukemia.
  Cancer Res Commun Volume: 3 Page(s): 1248 - 1259
  07/01/2023 Authors: Pillsbury CE; Dougan J; Rabe JL; Fonseca JA; Zhou C; Evans AN; Abukharma H; Ichoku O; Gonzalez-Flamenco G; Park SI
• ASSOCIATION BETWEEN ADVERSE EVENTS AND END OF INDUCTION MINIMAL RESIDUAL DISEASE IN PEDIATRIC ALL
  Volume: 70 Page(s): S51 - S52
  06/01/2023 Authors: Henderson M; DeGroote N; Ziworitin-Ogola C; Lau C; Jordan K; Byers E; West Z; Castellino S; Miller T
• HEMOGLOBIN A1C AND ASSOCIATION WITH TOXICITIES DURING INDUCTION FOR ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 70 Page(s): S54 - S55
  06/01/2023 Authors: Miller T; Strange L; DeGroote N; Henderson M; Bernardo S; Chukoian L; Clegg E; Lahey A; Schlesinger J; Wang P
• 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
  Hematol Oncol Volume: 41 Suppl 2 Page(s): 33 - 35
  06/01/2023 Authors: Herrera AF; LeBlanc M; Castellino SM; Li H; Rutherford SC; Evens AM; Davison K; Punnett A; Hodgson D; Parsons SK
• 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
  Hematol Oncol Volume: 41 Suppl 2 Page(s): 96 - 98
  06/01/2023 Authors: Alig SK; Esfahani MS; Garofalo A; Li MY; Rossi C; Adams R; Binkley MS; Jin MC; Olsen M; Telenius A
• 17th International Conference on Malignant Lymphoma, Palazzo dei Congressi, Lugano, Switzerland, 13 - 17 June, 2023.
  Hematol Oncol Volume: 41 Suppl 2 Page(s): 69
  06/01/2023 Authors: Casey D; McCarten K; Pei Q; Milgrom S; Belsky J; Cho S; Keller F; Punnett A; Hoppe B; Kelly K
• Survival in Young Adults With Cancer Is Associated With Medicaid Expansion Through the Affordable Care Act.
  J Clin Oncol Volume: 41 Page(s): 1909 - 1920
  04/01/2023 Authors: Ji X; Shi KS; Mertens AC; Zhao J; Yabroff KR; Castellino SM; Han X
• Characteristics and outcomes of pediatric oncology patients at risk for guardians declining transfusion of blood components.
  Cancer Rep (Hoboken) Volume: 6 Page(s): e1665
  01/01/2023 Authors: Stevenson J; DeGroote NP; Keller F; Brock KE; Bergsagel DJ; Miller TP; Cornwell P; Fasano R; Chonat S; Castellino SM
• Differences in palliative opportunities across diagnosis groups in children with cancer.
  Pediatr Blood Cancer Volume: 70 Page(s): e30081
  01/01/2023 Authors: Ebelhar J; DeGroote NP; Massie AM; Labudde E; Allen KE; Castellino SM; Wasilewski-Masker K; Brock KE
• Longitudinal use of patient reported outcomes in pediatric leukemia and lymphoma reveals clinically relevant symptomatic adverse events.
  Pediatr Blood Cancer Volume: 69 Page(s): e29986
  12/01/2022 Authors: Jacobs SS; Withycombe JS; Castellino SM; Lin L; Mack JW; McFatrich M; Baker JN; Freyer DR; Maurer SH; Mowbray C
• Infectious events in pediatric patients with acute lymphoblastic leukemia/lymphoma undergoing evaluation for fever without severe neutropenia.
  Cancer Volume: 128 Page(s): 4129 - 4138
  12/01/2022 Authors: Patel PA; DeGroote NP; Jackson K; Cash T; Castellino SM; Jaggi P; Esbenshade AJ; Miller TP
• Brentuximab Vedotin with Chemotherapy in Pediatric High-Risk Hodgkin's Lymphoma.
  N Engl J Med Volume: 387 Page(s): 1649 - 1660
  11/03/2022 Authors: Castellino SM; Pei Q; Parsons SK; Hodgson D; McCarten K; Horton T; Cho S; Wu Y; Punnett A; Dave H
• A Survey of Children's Oncology Group Hodgkin Lymphoma Members Regarding the Role of Radiotherapy in the Management of Pediatric Relapsed/Refractory Hodgkin Lymphoma
  Volume: 114 Page(s): E352 - E352
  11/01/2022 Authors: Vega RM; Harker-Murray PD; Forlenza CJ; Cole P; Kelly KM; Milgrom SA; Parikh RR; Hodgson D; Castellino S; Hoppe BS
• Implementation of a provider-focused intervention for maximizing human papillomavirus (HPV) vaccine uptake in young cancer survivors receiving follow-up care in pediatric oncology practices: protocol for a cluster-randomized trial of the HPV PROTECT intervention.
  BMC Pediatr Volume: 22 Page(s): 541
  09/12/2022 Authors: Landier W; Bhatia S; Richman JS; Campos Gonzalez PD; Cherven B; Chollette V; Aye J; Castellino SM; Gramatges MM; Lindemulder S
• Targeted radiotherapy for early-stage, low-risk pediatric Hodgkin lymphoma slow early responders: a COG AHOD0431 analysis.
  Blood Volume: 140 Page(s): 1086 - 1093
  09/08/2022 Authors: Parekh A; Keller FG; McCarten KM; Kessel S; Cho S; Pei Q; Wu Y; Castellino SM; Constine LS; Schwartz CL
• Can Steps per Day Reflect Symptoms in Children and Adolescents Undergoing Cancer Treatment?
  Cancer Nurs Volume: 45 Page(s): 345 - 353
  09/01/2022 Authors: Withycombe JS; McFatrich M; Hinds PS; Bennett A; Lin L; Maurer SH; Lucas NR; Mann CM; Castellino SM; Baker JN
• Rates of laboratory adverse events by course in paediatric leukaemia ascertained with automated electronic health record extraction: a retrospective cohort study from the Children's Oncology Group.
  Lancet Haematol Volume: 9 Page(s): e678 - e688
  09/01/2022 Authors: Miller TP; Getz KD; Li Y; Demissei BG; Adamson PC; Alonzo TA; Burrows E; Cao L; Castellino SM; Daves MH
• Automated Ascertainment of Typhlitis From the Electronic Health Record.
  JCO Clin Cancer Inform Volume: 6 Page(s): e2200081
  09/01/2022 Authors: Miller TP; Li Y; Masino AJ; Vallee E; Burrows E; Ramos M; Alonzo TA; Gerbing R; Castellino SM; Hawkins DS
• Evaluating Palliative Opportunities Across the Age Spectrum in Children and Adolescent Patients with Cancer.
  J Adolesc Young Adult Oncol Volume: 11 Page(s): 402 - 409
  08/01/2022 Authors: Labudde EJ; DeGroote NP; Ebelhar J; Massie AM; Allen KE; Castellino SM; Wasilewski-Masker K; Brock KE
• Racial Disparities in Children, Adolescents, and Young Adults with Hodgkin Lymphoma Enrolled in the New York State Medicaid Program.
  J Adolesc Young Adult Oncol Volume: 11 Page(s): 360 - 369
  08/01/2022 Authors: Kahn JM; Zhang X; Kahn AR; Castellino SM; Neugut AI; Schymura MJ; Boscoe FP; Keegan THM
• Metabolites Associated With Fatigue and Physical Activity in Childhood Cancer.
  Biol Res Nurs Volume: 24 Page(s): 350 - 361
  07/01/2022 Authors: Withycombe JS; Eldridge R; Jin Y; Gu H; Castellino SM; Sears DD
• ENRICHMENT OF HIGH-RISK INNATE IMMUNE CELLS IN HISPANIC AND BLACK CHILDREN WITH B-ALL
  Volume: 69
  06/01/2022 Authors: Gilbert J; Sabnis H; Radzievski R; Doxie D; DeRyckere D; Castellino S; Dhodapkar K
• AUTOMATED ELECTRONIC HEALTH RECORD ASCERTAINMENT OF TYPHLITIS: A CHILDREN'S ONCOLOGY GROUP REPORT
  Volume: 69
  06/01/2022 Authors: Miller TP; Li Y; Masino A; Vallee E; Burrows E; Castellino S; Hawkins D; Ramos M; Lash T; Aplenc R
• COMPLICATIONS BY CENTRAL LINE TYPE DURING INDUCTION CHEMOTHERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 69
  06/01/2022 Authors: Degroote N; Joshi V; West Z; Bathina N; Castellino S; Miller T
• SIGNIFICANT BURDEN OF ADVERSE EVENTS DURING THERAPY FOR T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA/LYMPHOMA
  Volume: 69
  06/01/2022 Authors: Summers R; Monroig V; DeGroote N; West Z; Katafias E; Castellino S; Miller T
• TRAJECTORY OF HYPERGLYCEMIA IN PEDIATRIC ACUTE LYMPHOBLASTIC LEUKEMIA (ALL)
  Volume: 69
  06/01/2022 Authors: Lederer S; DeGroote N; Josh V; West Z; Castellino S; Miller T
• Moving Beyond Patient-Level Drivers of Racial/Ethnic Disparities in Childhood Cancer.
  Cancer Epidemiol Biomarkers Prev Volume: 31 Page(s): 1154 - 1158
  06/01/2022 Authors: Ji X; Sohn H; Sil S; Castellino SM
• Association of race/ethnicity with innate immune tumor microenvironment of children with B-acute lymphoblastic leukemia.
  J Immunother Cancer Volume: 10
  06/01/2022 Authors: Gilbert JR; Sabnis HS; Radzievski R; Doxie DB; DeRyckere D; Castellino SM; Dhodapkar K
• Comprehensive Genomic Profiling of High-Risk Pediatric Cancer Patients Has a Measurable Impact on Clinical Care.
  JCO Precis Oncol Volume: 6 Page(s): e2100451
  04/01/2022 Authors: Summers RJ; Castellino SM; Porter CC; MacDonald TJ; Basu GD; Szelinger S; Bhasin MK; Cash T; Carter AB; Castellino RC
• Narrowing Insurance Disparities Among Children and Adolescents With Cancer Following the Affordable Care Act.
  JNCI Cancer Spectr Volume: 6
  01/05/2022 Authors: Ji X; Hu X; Castellino SM; Mertens AC; Yabroff KR; Han X
• Survival by age in paediatric and adolescent patients with Hodgkin lymphoma: a retrospective pooled analysis of children's oncology group trials.
  Lancet Haematol Volume: 9 Page(s): e49 - e57
  01/01/2022 Authors: Kahn JM; Pei Q; Friedman DL; Kaplan J; Keller FG; Hodgson D; Wu Y; Appel BE; Bhatia S; Henderson TO
• Evaluating Disparities in Proton Radiation Therapy Use in AHOD1331, a Contemporary Children's Oncology Group Trial for Advanced-Stage Hodgkin Lymphoma.
  Int J Part Ther Volume: 8 Page(s): 55 - 57
  01/01/2022 Authors: Mailhot Vega RB; Castellino SM; Pei Q; Parsons S; Roberts KB; Hodgson D; Charpentier A-M; Fitzgerald TJ; Kessel SK; Keller FG
• Combination brentuximab vedotin and bendamustine for pediatric patients with relapsed/refractory Hodgkin lymphoma.
  Blood Adv Volume: 5 Page(s): 5519 - 5524
  12/28/2021 Authors: Forlenza CJ; Gulati N; Mauguen A; Absalon MJ; Castellino SM; Franklin A; Keller FG; Shukla N
• Multicenter Analysis of Genomically Targeted Single Patient Use Requests for Pediatric Neoplasms.
  J Clin Oncol Volume: 39 Page(s): 3822 - 3828
  12/01/2021 Authors: Sabnis HS; Shulman DS; Mizukawa B; Bouvier N; Zehir A; Fangusaro J; Fabrizio VA; Whitlow C; Winchester M; Agresta L
• Association of Medicaid Expansion With Cancer Stage and Disparities in Newly Diagnosed Young Adults.
  J Natl Cancer Inst Volume: 113 Page(s): 1723 - 1732
  11/29/2021 Authors: Ji X; Castellino SM; Mertens AC; Zhao J; Nogueira L; Jemal A; Yabroff KR; Han X
• Late hepatic toxicity surveillance for survivors of childhood, adolescent and young adult cancer: Recommendations from the international late effects of childhood cancer guideline harmonization group.
  Cancer Treat Rev Volume: 100 Page(s): 102296
  11/01/2021 Authors: Bardi E; Mulder RL; van Dalen EC; Bhatt NS; Ruble KA; Burgis J; Castellino SM; Constine LS; den Hoed CM; Green DM
• Differences in Palliative Opportunities Across Diagnosis Groups in Children with Cancer
  Volume: 68 Page(s): S334 - S334
  11/01/2021 Authors: Ebelhar J; Degroote N; Labudde E; Massie A; Allen K; Castellino S; Wasilewski-Masker K; Brock K
• Patients, caregivers, and clinicians differ in performance status ratings: Implications for pediatric cancer clinical trials.
  Cancer Volume: 127 Page(s): 3664 - 3670
  10/01/2021 Authors: Maurer SH; Hinds PS; Reeve BB; Mack JW; McFatrich M; Lin L; Withycombe JS; Jacobs SS; Baker JN; Castellino SM
• Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study.
  J Clin Oncol Volume: 39 Page(s): 2266 - 2275
  07/10/2021 Authors: Oeffinger KC; Stratton KL; Hudson MM; Leisenring WM; Henderson TO; Howell RM; Wolden SL; Constine LS; Diller LR; Sklar CA
• Integration of Pediatric Hodgkin Lymphoma Treatment and Late Effects Guidelines: Seeing the Forest Beyond the Trees.
  J Natl Compr Canc Netw Volume: 19 Page(s): 755 - 764
  06/30/2021 Authors: Ehrhardt MJ; Flerlage JE; Armenian SH; Castellino SM; Hodgson DC; Hudson MM
• DIFFERENCES IN PALLIATIVE OPPORTUNITIES ACROSS DIAGNOSIS GROUPS IN CHILDREN WITH CANCER
  Volume: 68 Page(s): S85 - S85
  06/01/2021 Authors: Ebelhar J; DeGroote N; Labudde E; Massie AM; Allen K; Castellino S; Wasilewski-Masker K; Brock K
• CHARACTERISTICS AND OUTCOMES OF PEDIATRIC ONCOLOGY PATIENTS AT RISK FOR TRANSFUSION REFUSAL
  Volume: 68 Page(s): S97 - S98
  06/01/2021 Authors: Stevenson J; DeGroote N; Choudhury T; Keller F; Brock K; Bergsagel DJ; Miller T; Cornwell P; Chonat S; Castellino S
• PREDICTORS AND OUTCOMES OF IMMUNOGLOBULIN SUPPLEMENTATION IN B-CELL ACUTE LYMPHOBLASTIC LEUKEMIA
  Volume: 68 Page(s): S53 - S53
  06/01/2021 Authors: Edington H; DeGroote N; Miller T; Stevenson J; Chandrakasan S; Mertens A; Castellino S
• Patterns of surveillance for late effects of BCR-ABL tyrosine kinase inhibitors in survivors of pediatric Philadelphia chromosome positive leukemias.
  BMC Cancer Volume: 21 Page(s): 474
  04/29/2021 Authors: Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel J; Patterson B; Mertens A; Sakamoto KM; Schapira L; Castellino SM
• Quantifying the difference in risk of adverse events by induction treatment regimen in pediatric acute lymphoblastic leukemia.
  Leuk Lymphoma Volume: 62 Page(s): 899 - 908
  04/01/2021 Authors: West ZE; Castellino SM; Monroe C; Thomas AS; McCracken C; Miller TP
• Evaluating palliative opportunities in pediatric patients with leukemia and lymphoma.
  Cancer Med Volume: 10 Page(s): 2714 - 2722
  04/01/2021 Authors: Labudde EJ; DeGroote NP; Smith S; Ebelhar J; Allen KE; Castellino SM; Wasilewski-Masker K; Brock KE
• Renal and Hepatic Health After Childhood Cancer.
  Volume: 67 Page(s): 1203 - 1217
  12/01/2020 Authors: Ehrhardt MJ; Skinner R; Castellino SM
• Frequency and Timing of Palliative Opportunities in Pediatric Patients with Hematologic Malignancies
  Volume: 136
  11/05/2020 Authors: Labudde EJ; DeGroote NP; Smith S; Ebelhar J; Castellino SM; Wasilewski-Masker K; Brock KE
• Single Cell Transcriptomics Revealed AML and Non-AML Cell Clusters Relevant to Relapse and Remission in Pediatric AML
  Volume: 136
  11/05/2020 Authors: Thomas BE; Perumalla P; Bhasin SS; Sarkar D; Dwivedi B; Park SI; DeRyckere D; Henry CJ; Raikar SS; Porter CC
• Infectious Outcomes of Pediatric Acute Lymphoblastic Leukemia Patients Presenting with Non-Neutropenic Fever
  Volume: 136
  11/05/2020 Authors: Patel PA; DeGroote NP; Esbenshade AJ; Cash WT; Castellino SM; Jaggi P; Miller TP
• Melphalan induces cardiotoxicity through oxidative stress in cardiomyocytes derived from human induced pluripotent stem cells.
  Stem Cell Res Ther Volume: 11 Page(s): 470
  11/05/2020 Authors: Liu R; Li D; Sun F; Rampoldi A; Maxwell JT; Wu R; Fischbach P; Castellino SM; Du Y; Fu H
• Validity and Reliability of the Pediatric Patient-Reported Outcomes version of the Common Terminology Criteria for Adverse Events.
  J Natl Cancer Inst Volume: 112 Page(s): 1143 - 1152
  11/01/2020 Authors: Reeve BB; McFatrich M; Mack JW; Maurer SH; Jacobs SS; Freyer DR; Withycombe JS; Baker JN; Castellino SM; Lin L
• Impact of respiratory viral panel testing on length of stay in pediatric cancer patients admitted with fever and neutropenia.
  Pediatr Blood Cancer Volume: 67 Page(s): e28570
  11/01/2020 Authors: Shinn K; Wetzel M; DeGroote NP; Keller F; Briones M; Felker J; Castellino S; Miller TP
• Association of GSTM1 null variant with anthracycline-related cardiomyopathy after childhood cancer-A Children's Oncology Group ALTE03N1 report.
  Cancer Volume: 126 Page(s): 4051 - 4058
  09/01/2020 Authors: Singh P; Wang X; Hageman L; Chen Y; Magdy T; Landier W; Ginsberg JP; Neglia JP; Sklar CA; Castellino SM
• A strategy to reduce cumulative anthracycline exposure in low-risk pediatric acute myeloid leukemia while maintaining favorable outcomes.
  Leuk Res Volume: 96 Page(s): 106421
  09/01/2020 Authors: Sabnis HS; Minson KA; Monroe C; Allen K; Metts JL; Cooper TM; Woods WG; Castellino SM; Keller FG
• Risk-associated alterations in marrow T cells in pediatric leukemia.
  JCI Insight Volume: 5
  08/20/2020 Authors: Bailur JK; McCachren SS; Pendleton K; Vasquez JC; Lim HS; Duffy A; Doxie DB; Kaushal A; Foster C; DeRyckere D
• Dealing with a critical national shortage-Approaches to triaging immune globulin supply in pediatric hematology and oncology.
  Pediatr Blood Cancer Volume: 67 Page(s): e28260
  07/01/2020 Authors: Edington HJ; Sutton KS; Bennett C; Chandrakasan S; Sterner-Allison J; Castellino SM
• Targeted therapies for children and young adults with cancer: Single-patient use (SPU) experience at three large pediatric cancer programs
  Volume: 80 Page(s): 69 - 70
  07/01/2020 Authors: Sabnis H; Mizukawa B; Glade-Bender J; Fangusaro J; Roberts S; Whitlow C; Winchester M; O'Brien M; Agresta L; Turpin B
• NEXT-GENERATION SEQUENCING REVEALS INCREASED PREVALENCE OF PICALM-MLLT10 FUSIONS IN T-ALL AND T-LLY
  Volume: 67 Page(s): S167 - S167
  06/01/2020 Authors: Summers R; Aumann W; Pauly M; Goldsmith K; Porter C; Worsley R; Graham D; Castellino S; Wechsler D
• INCIDENT FOCAL NODULAR HYPERPLASIA (FNH) AND ASSOCIATED RISK FACTORS IN PEDIATRIC CANCER SURVIVORS
  Volume: 67 Page(s): S206 - S207
  06/01/2020 Authors: Wallace A; Lewis RW; Castellino S; Effinger K
• Survival by race and ethnicity in pediatric and adolescent patients with Hodgkin lymphoma: A report from the Children's Oncology Group
  Volume: 29
  06/01/2020 Authors: Kahn J; Kelly KM; Pei Q; Bush R; Friedman DL; Keller FG; Bhatia S; Henderson TO; Schwartz CL; Castellino SM
• Screening practices for late effects in pediatric patients on tyrosine kinase inhibitors.
  Volume: 38
  05/20/2020 Authors: Smith SM; Sabnis HS; Lewis RW; Effinger KE; Bergsagel DJ; Patterson B; Mertens AC; Sakamoto K; Schapira L; Castellino SM
• A randomized Phase III trial of Brentuximab vedotin (Bv) for de novo High-Risk Classical Hodgkin Lymphoma (cHL) in children and adolescents - Study Design and Incorporation of secondary endpoints in Children's Oncology Group (COG) AHOD1331
  Volume: 232 Page(s): 82 - 83
  03/01/2020 Authors: Castellino SM; Parsons SK; Pei Q; McCarten K; Kessel S; Punnett A; Horton TM; Henderson TO; Hodgson D; Dave H
• Assessment of tumor antigen specific T cell immunity and cytokine milieu at diagnosis in patients with high risk Hodgkin Lymphoma treated on Children's Oncology Group trial AHOD1331
  Volume: 232 Page(s): 87 - 87
  03/01/2020 Authors: Dave H; Horton TM; Mai M; Saunders D; Jenkins G; Pei Q; Keller FG; Castellino SM; Kelly KM; Bollard C
• Outcomes by age in pediatric and adolescent patients treated for de novo Hodgkin lymphoma on contemporary Children's Oncology Group trials
  Volume: 232 Page(s): 112 - 112
  03/01/2020 Authors: Kahn JM; Kelly KM; Pei Q; Friedman DL; Keller FG; Bhatia S; Henderson TO; Schwartz CL; Castellino SM
• Access to proton beam therapy (PBT) for patients with large mediastinal adenopathy (LMA)
  Volume: 232 Page(s): 108 - 108
  03/01/2020 Authors: Vega CMRB; Hoppe BS; Hodgson D; Charpentier AM; Fitzgerald TJ; Kessel S; Pei Q; Keller FG; Parsons SK; Kelly KM
• An Intergroup Approach for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Adolescents and Young Adults (AYA): SWOG S1826
  Volume: 232 Page(s): 91 - 92
  03/01/2020 Authors: Castellino SM; LeBlanc M; Herrera A; Parsons SK; Punnett A; Hodgson D; Rutherford S; Kahn N; Constine LS; Davison K
• Impact of central review of imaging in an FDG-PET response adapted Pediatric Hodgkin lymphoma protocol
  Volume: 232 Page(s): 111 - 111
  03/01/2020 Authors: Hoppe BS; Castellino SM; Kessel S; Alazraki A; Voss S; Mhlanga J; Lai H; Eutsler E; Keller FG; Kelly KM
• Reduction in Cardiac Radiation Dose Among Children Receiving Mediastinal RT: Comparison of Involved-Site vs Involved-Field RT Delivered in Three Children's Oncology Group Trials
  Volume: 232 Page(s): 102 - 103
  03/01/2020 Authors: Gravel BS; Khandwala M; Wolden SL; Castellino SM; Friedman DL; Kelly KM; Roberts KB; Constine LS; Schwartz CL; Fitzgerald TJ
• Impact of fluid overload and infection on respiratory adverse event development during induction therapy for childhood acute myeloid leukemia.
  Pediatr Blood Cancer Volume: 66 Page(s): e27975
  12/01/2019 Authors: Miller LH; Keller F; Mertens A; Klein M; Allen K; Castellino S; Woods WG
• Closing the survivorship gap in children and adolescents with Hodgkin lymphoma.
  Br J Haematol Volume: 187 Page(s): 573 - 587
  12/01/2019 Authors: Castellino SM; Parsons SK; Kelly KM
• Adverse Events during Induction Therapy in Pediatric Acute Lymphoblastic Lymphoma (ALL)
  Volume: 134
  11/13/2019 Authors: West Z; Allen K; Monroe C; Castellino SM; Miller TP
• Survival by Race and Ethnicity in Pediatric and Adolescent Patients With Hodgkin Lymphoma: A Children's Oncology Group Study.
  J Clin Oncol Volume: 37 Page(s): 3009 - 3017
  11/10/2019 Authors: Kahn JM; Kelly KM; Pei Q; Bush R; Friedman DL; Keller FG; Bhatia S; Henderson TO; Schwartz CL; Castellino SM
• Intent and subsequent initiation of human papillomavirus vaccine among young cancer survivors.
  Cancer Volume: 125 Page(s): 3810 - 3817
  11/01/2019 Authors: Cherven B; Castellino SM; Chen Y; Wong FL; York JM; Wasilewski-Masker K; Hudson MM; Bhatia S; Klosky JL; Landier W
• Suboptimal uptake of human papillomavirus (HPV) vaccine in survivors of childhood and adolescent and young adult (AYA) cancer.
  J Cancer Surviv Volume: 13 Page(s): 730 - 738
  10/01/2019 Authors: Castellino SM; Allen KE; Pleasant K; Keyes G; Poehling KA; Tooze JA
• Assessing how a child with cancer functions using patient-reported and objective physical activity data
  Volume: 28 Page(s): S58 - S58
  10/01/2019 Authors: McFatrich M; Mann CM; Bennett AV; Withycombe JS; Castellino SM; Baker JN; Lin L; Wang M; Hinds PS; Maurer SH
• Psychometric evaluation of the pediatric patient-reported outcomes version of the common terminology criteria for adverse events (Pediatric PRO-CTCAE)
  Volume: 28 Page(s): S20 - S21
  10/01/2019 Authors: Reeve B; McFatrich M; Lin L; Lucas N; Castellino S; Withycombe J; Jacobs S; Mack J; Freyer D; Baker J
• CLINICAL TRIAL PARTICIPATION DIFFERS BY PARENTAL PRIMARY LANGUAGE IN PEDIATRIC LEUKEMIA PATIENTS
  Volume: 66
  06/01/2019 Authors: Monroe C; Allen K; Mertens A; Castellino S
• A novel association between GSTM1 null variant and anthracycline-induced cardiac dysfunction (ACD) in childhood cancer survivors (CCS): A COG ALTE03N1 report.
  Volume: 37
  05/20/2019 Authors: Singh P; Wang X; Hageman L; Chen Y; Magdy T; Landier W; Ginsberg JP; Neglia JP; Sklar CA; Castellino SM
• Evaluating approaches to enhance survival in children with hypodiploid acute lymphoblastic leukaemia (ALL).
  Br J Haematol Volume: 185 Page(s): 613 - 616
  05/01/2019 Authors: Miller L; Kobayashi S; Pauly M; Lew G; Saxe D; Keller F; Qayed M; Castellino S
• Growth disturbances in children and adolescents receiving long-term tyrosine kinase inhibitor therapy for Chronic Myeloid Leukaemia or Philadelphia Chromosome-positive Acute Lymphoblastic Leukaemia.
  Br J Haematol Volume: 185 Page(s): 795 - 799
  05/01/2019 Authors: Sabnis HS; Keenum C; Lewis RW; Patterson B; Bergsagel J; Effinger KE; Silverman E; Mertens AC; Castellino SM
• Hepatic late adverse effects after antineoplastic treatment for childhood cancer.
  Cochrane Database Syst Rev Volume: 4 Page(s): CD008205
  04/15/2019 Authors: Mulder RL; Bresters D; Van den Hof M; Koot BG; Castellino SM; Loke YKK; Post PN; Postma A; Sznyi LP; Levitt GA
• Incidence and outcomes of lymphoid malignancies in adolescent and young adult patients in the United States.
  Br J Haematol Volume: 183 Page(s): 385 - 399
  11/01/2018 Authors: Blum KA; Keller FG; Castellino S; Phan A; Flowers CR
• Results of the AHOD0431 trial of response adapted therapy and a salvage strategy for limited stage, classical Hodgkin lymphoma: A report from the Children's Oncology Group.
  Cancer Volume: 124 Page(s): 3210 - 3219
  08/01/2018 Authors: Keller FG; Castellino SM; Chen L; Pei Q; Voss SD; McCarten KM; Senn SL; Buxton AB; Bush R; Constine LS
• Early-stage Hodgkin lymphoma in the modern era: simulation modelling to delineate long-term patient outcomes.
  Br J Haematol Volume: 182 Page(s): 212 - 221
  07/01/2018 Authors: Parsons SK; Kelly MJ; Cohen JT; Castellino SM; Henderson TO; Kelly KM; Keller FG; Henzer TJ; Kumar AJ; Johnson P
• Left Ventricular Mass Change After Anthracycline Chemotherapy.
  Circ Heart Fail Volume: 11 Page(s): e004560
  07/01/2018 Authors: Jordan JH; Castellino SM; Melndez GC; Klepin HD; Ellis LR; Lamar Z; Vasu S; Kitzman DW; Ntim WO; Brubaker PH
• ALLOPURINOL USE WITH 6-MERCAPTOPURINE IN MAINTENANCE THERAPY FOR ACUTE LYMPHOBLASTIC LEUKEMIA: A CASE SERIES
  PEDIATRIC BLOOD & CANCER Volume: 65
  06/01/2018 Authors: Phillips L; Minson K; Castellino S; Bergsagel J; Lew G; Sabnis H; Pauly M; Keller F
• OUTCOMES WITHIN FIVE YEARS FROM THERAPY COMPLETION IN PEDIATRIC HODGKIN LYMPHOMA PATIENTS FOLLOWING CONTEMPORARY THERAPY
  PEDIATRIC BLOOD & CANCER Volume: 65
  06/01/2018 Authors: Effinger K; Keller F; Bergsagel J; Lawrence T; Lewis RW; Meacham L; Mertens A; Castellino S
• INCIDENCE AND PREDICTORS OF RESPIRATORY ADVERSE EVENTS DURING INDUCTION THERAPY IN CHILDREN WITH ACUTE MYELOID LEUKEMIA
  Volume: 65
  06/01/2018 Authors: Miller L; Castellino S; Mertens A; Keller F; Woods W
• WORKING TO STANDARDIZE CARDIOLOGY CARE IN SURVIVORS OF CHILDHOOD CANCER: A PEDIATRIC CARDIO-ONCOLOGY SCORE
  Volume: 65
  06/01/2018 Authors: Effinger K; Border W; Rose-Felker K; Record E; Mertens A; Castellino S; Meacham L
• Cost, Value, and Financial Hardship in Cancer Care: Implications for Pediatric Oncology.
  Am Soc Clin Oncol Educ Book Volume: 38 Page(s): 850 - 860
  05/23/2018 Authors: Parsons SK; Castellino SM; Yabroff KR
• Risk-adapted therapy for pediatric Hodgkin lymphoma (HL) results in lower risk of late effects: a report from the Childhood Cancer Survivor Study (CCSS).
  Volume: 36
  05/20/2018 Authors: Oeffinger KC; Stratton K; Hudson MM; Leisenring W; Howell RM; Wolden SL; Constine LS; Diller L; Henderson TO; Sklar CA
• Incidence and Predictors of Adverse Respiratory Events during Induction Therapy in Children with Acute Myeloid Leukemia
  Volume: 130
  12/07/2017 Authors: Miller L; Castellino SM; Mertens A; Keller FG; Woods WG
• Comment on: Value of flow cytometric analysis of peripheral blood samples in children diagnosed with acute lymphoblastic leukemia.
  Pediatr Blood Cancer Volume: 65
  10/08/2017 Authors: Summers RJ; Metrock LK; Park S; Gillespie S; Castellino S; Lew G; Keller FG
• Utility of peripheral blood immunophenotyping by flow cytometry in the diagnosis of pediatric acute leukemia.
  Pediatr Blood Cancer Volume: 64
  10/01/2017 Authors: Metrock LK; Summers RJ; Park S; Gillespie S; Castellino S; Lew G; Keller FG
• Approach and Feasibility of Patient-Reported Outcomes (PROs) in a Phase III Clinical Trial for Advanced Stage Classical Hodgkin Lymphoma (cHL) in Children and Adolescents
  Volume: 128
  12/02/2016 Authors: Henderson TO; Castellino SM; Keller FG; Kelly KM; Curtis R; Conti RM; Parsons SK
• APPROACH AND FEASIBILITY OF PATIENT-REPORTED OUTCOMES IN A PHASE III CLINICAL TRIAL FOR ADVANCED STAGE CLASSICAL HODGKIN LYMPHOMA IN CHILDREN AND ADOLESCENTS
  HAEMATOLOGICA Volume: 101 Page(s): 37 - 37
  10/01/2016 Authors: Castellino SM; Henderson TO; Keller F; Kelly K; Curtis R; Conti RM; Parsons SK
• Patterns and predictors of clustered risky health behaviors among adult survivors of childhood cancer: A report from the Childhood Cancer Survivor Study.
  Cancer Volume: 122 Page(s): 2747 - 2756
  09/01/2016 Authors: Lown EA; Hijiya N; Zhang N; Srivastava DK; Leisenring WM; Nathan PC; Castellino SM; Devine KA; Dilley K; Krull KR
• Occult Gastrointestinal Bleeding in a 15-Year-Old Pediatric Cancer Survivor.
  J Pediatr Gastroenterol Nutr Volume: 62 Page(s): e62 - e63
  06/01/2016 Authors: Grimes K; Kratzer T; Russo K; Bourland D; Castellino S
• A POPULATION BASED STUDY OF UPTAKE OF HUMAN PAPILLOMA VIRUS (HPV) VACCINE IN CANCER SURVIVORS
  Volume: 63 Page(s): S54 - S54
  06/01/2016 Authors: Castellino S; Pleasant K; Poehling K; Tooze J
• PRESCRIBED DOSES OF MAINTENANCE ORAL CHEMOTHERAPY IN THE TREATMENT OF ACUTE LYMPHOBLASTIC LEUKEMIA VARIES BY PATIENT RACE
  PEDIATRIC BLOOD & CANCER Volume: 63 Page(s): S43 - S44
  06/01/2016 Authors: Pauly M; Lee B; Travers C; Lew G; Sabnis H; Castellino S
• Late Effects Surveillance Recommendations among Survivors of Childhood Hematopoietic Cell Transplantation: A Children's Oncology Group Report.
  Biol Blood Marrow Transplant Volume: 22 Page(s): 782 - 795
  05/01/2016 Authors: Chow EJ; Anderson L; Baker KS; Bhatia S; Guilcher GMT; Huang JT; Pelletier W; Perkins JL; Rivard LS; Schechter T
• CELF4 Variant and Anthracycline-Related Cardiomyopathy: A Children's Oncology Group Genome-Wide Association Study.
  J Clin Oncol Volume: 34 Page(s): 863 - 870
  03/10/2016 Authors: Wang X; Sun C-L; Quiones-Lombraa A; Singh P; Landier W; Hageman L; Mather M; Rotter JI; Taylor KD; Chen Y-DI
• An Adjustable Markov Model to Project Life Expectancy (LE) for Early Stage Favorable Risk Hodgkin Lymphoma Patients Treated with Contemporary Therapy
  Volume: 126
  12/03/2015 Authors: Kelly MJ; Parsons SK; Hodgson DC; Cohen JT; Yeh JM; Abramson JS; Friedman DL; Henderson TO; Johnson PW; Pauker SG
• Angiotensin-(1-7) prevents fibrosis in doxorubicin-treated rats
  Volume: 75
  08/01/2015 Authors: Rahimi OA; Castellino SM; Cammock CE; Tallant EA; Gallagher PE
• CELF4 variant and Anthracycline-related Cardiomyopathy (anth-card) - A COG Study (ALTE03N1).
  Volume: 33
  05/20/2015 Authors: Wang X; Sun C-L; Lombrana AQ; Singh P; Landier W; Hageman L; Mather M; Chen L; Armenian S; Winick NJ
• Adolescent and Young Adult (AYA) Oncology in the United States: A Specialty in Its Late Adolescence.
  J Pediatr Hematol Oncol Volume: 37 Page(s): 161 - 169
  04/01/2015 Authors: Shaw PH; Reed DR; Yeager N; Zebrack B; Castellino SM; Bleyer A
• Age-dependent changes in health status in the Childhood Cancer Survivor cohort.
  J Clin Oncol Volume: 33 Page(s): 479 - 491
  02/10/2015 Authors: Hudson MM; Oeffinger KC; Jones K; Brinkman TM; Krull KR; Mulrooney DA; Mertens A; Castellino SM; Casillas J; Gurney JG
• Germ-line and somatic SMARCA4 mutations characterize small cell carcinoma of the ovary, hypercalcemic type
  Volume: 74
  10/01/2014 Authors: Witkowski L; Carrot-Zhang J; Albrecht S; Hamel N; Tomiak E; Grynspan D; Saloustros E; Gilpin C; Silva-Smith R; Plourde F
• Decline in physical activity level in the Childhood Cancer Survivor Study cohort.
  Cancer Epidemiol Biomarkers Prev Volume: 23 Page(s): 1619 - 1627
  08/01/2014 Authors: Wilson CL; Stratton K; Leisenring WL; Oeffinger KC; Nathan PC; Wasilewski-Masker K; Hudson MM; Castellino SM; Stovall M; Armstrong GT
• Developing interventions for cancer-related cognitive dysfunction in childhood cancer survivors.
  J Natl Cancer Inst Volume: 106
  08/01/2014 Authors: Castellino SM; Ullrich NJ; Whelen MJ; Lange BJ
• Oral and dental late effects in survivors of childhood cancer: a Children's Oncology Group report.
  Support Care Cancer Volume: 22 Page(s): 2009 - 2019
  07/01/2014 Authors: Effinger KE; Migliorati CA; Hudson MM; McMullen KP; Kaste SC; Ruble K; Guilcher GMT; Shah AJ; Castellino SM
• UTILITY OF PERIPHERAL BLOOD IMMUNOPHENOTYPING BY FLOW CYTOMETRY IN THE DIAGNOSIS OF PEDIATRIC LEUKEMIA
  Volume: 61 Page(s): S84 - S84
  05/01/2014 Authors: Summers R; Williamson L; Gillespie S; Park S; Lew G; Keller F
• Hyaluronan synthase 3 variant and anthracycline-related cardiomyopathy: a report from the children's oncology group.
  J Clin Oncol Volume: 32 Page(s): 647 - 653
  03/01/2014 Authors: Wang X; Liu W; Sun C-L; Armenian SH; Hakonarson H; Hageman L; Ding Y; Landier W; Blanco JG; Chen L
• Pathologic Atrophy of the Left Ventricular Myocardium Early After Receipt of Anthracycline-Based Chemotherapy
  Volume: 128
  11/26/2013 Authors: Jordan JH; Morgan TM; Ellis LR; Lawrence J; Hall ME; Castellino SM; Hamilton CA; Torti FM; Vasu S; D'Agostino RB
• A review of contemporary options for medical management of hemangiomas, other vascular tumors, and vascular malformations.
  Pharmacol Ther Volume: 139 Page(s): 327 - 333
  09/01/2013 Authors: Blatt J; McLean TW; Castellino SM; Burkhart CN
• Potential Role of Community-Based Healthcare System Data in Research on Survivors of Adolescent and Young Adult Cancer.
  J Adolesc Young Adult Oncol Volume: 2 Page(s): 53 - 58
  06/01/2013 Authors: Geiger AM; Castellino SM; Tooze JA; Altschuler A; Month S; Mertens AC; Nekhlyudov L; Greene SM
• Hyaluronidase synthase 3 (HAS3) variant and anthracycline-related cardiomyopathy: A report from the Children's Oncology Group.
  Volume: 31
  05/20/2013 Authors: Sun C-L; Wang X; Liu W; Armenian S; Hankonarson H; Hageman L; Ding Y; Landier W; Keller FG; Neglia JP
• Predictors of declining levels of physical activity among adult survivors of childhood cancer
  Volume: 31
  05/20/2013 Authors: Wilson CL; Leisenring WM; Oeffinger KC; Nathan PC; Wasilewski-Masker K; Hudson MM; Castellino SM; Stovall M; Armstrong GT; Brinkman TM
• Toxicity and efficacy of the acetylcholinesterase (AChe) inhibitor donepezil in childhood brain tumor survivors: a pilot study.
  Pediatr Blood Cancer Volume: 59 Page(s): 540 - 547
  09/01/2012 Authors: Castellino SM; Tooze JA; Flowers L; Hill DF; McMullen KP; Shaw EG; Parsons SK
• LONGITUDINAL CHANGES IN HEALTH STATUS OF THE CHILDHOOD CANCER SURVIVOR COHORT
  PEDIATRIC BLOOD & CANCER Volume: 57 Page(s): 713 - 713
  11/01/2011 Authors: Hudson M; Hudson M; Oeffinger K; Nathan P; Mertens A; Castellino S; Mulrooney D; Gurneys J; Armstrong G; Leisenringth W
• The peabody picture vocabulary test as a pre-screening tool for global cognitive functioning in childhood brain tumor survivors.
  J Neurooncol Volume: 104 Page(s): 559 - 563
  09/01/2011 Authors: Castellino SM; Tooze JA; Flowers L; Parsons SK
• Delineating the age ranges used to define adolescents and young adults.
  J Clin Oncol Volume: 29 Page(s): e492 - e493
  06/01/2011 Authors: Geiger AM; Castellino SM
• CHILDREN AND ADOLESCENTS WITH LOW RISK HODGKIN LYMPHOMA (HL)
  PEDIATRIC BLOOD & CANCER Volume: 56 Page(s): 883 - 883
  05/01/2011 Authors: Castellino S; Keller F; Dunphy C; McCarten K; Thomson J; Voss S; Nachman J; Constine L; Chen L; Schwartz C
• Impact of insurance type on survivor-focused and general preventive health care utilization in adult survivors of childhood cancer: the Childhood Cancer Survivor Study (CCSS).
  Cancer Volume: 117 Page(s): 1966 - 1975
  05/01/2011 Authors: Casillas J; Castellino SM; Hudson MM; Mertens AC; Lima ISF; Liu Q; Zeltzer LK; Yasui Y; Robison LL; Oeffinger KC
• Angiotensin-(1-7) inhibits the growth of human pediatric rhabdomyosarcoma in a mouse xenograft model
  CANCER RESEARCH Volume: 71
  04/15/2011 Authors: Gallagher PE; Maglic D; Krishnan B; Castellino SM; Tallant EA
• Morbidity and mortality in long-term survivors of Hodgkin lymphoma: a report from the Childhood Cancer Survivor Study.
  Blood Volume: 117 Page(s): 1806 - 1816
  02/10/2011 Authors: Castellino SM; Geiger AM; Mertens AC; Leisenring WM; Tooze JA; Goodman P; Stovall M; Robison LL; Hudson MM
• Hepato-biliary late effects in survivors of childhood and adolescent cancer: a report from the Children's Oncology Group.
  Pediatr Blood Cancer Volume: 54 Page(s): 663 - 669
  05/01/2010 Authors: Castellino S; Muir A; Shah A; Shope S; McMullen K; Ruble K; Barber A; Davidoff A; Hudson MM
• Knowledge of hepatitis C virus screening in long-term pediatric cancer survivors: a report from the Childhood Cancer Survivor Study.
  Cancer Volume: 116 Page(s): 974 - 982
  02/15/2010 Authors: Lansdale M; Castellino S; Marina N; Goodman P; Hudson MM; Mertens AC; Smith SM; Leisenring W; Robison LL; Oeffinger KC
• Familial small cell carcinoma of the ovary.
  Pediatr Blood Cancer Volume: 53 Page(s): 1334 - 1336
  12/15/2009 Authors: Martinez-Borges AR; Petty JK; Hurt G; Stribling JT; Press JZ; Castellino SM
• What is the best treatment for children with limited-stage Hodgkin lymphoma?
  Curr Hematol Malig Rep Volume: 4 Page(s): 129 - 135
  07/01/2009 Authors: Keller FG; Castellino SM; Nachman JB
• Pediatric genitourinary tumors.
  Curr Opin Oncol Volume: 21 Page(s): 278 - 283
  05/01/2009 Authors: Castellino SM; Martinez-Borges AR; McLean TW
• Cardiac myxoma after treatment for childhood neuroblastoma.
  Pediatr Cardiol Volume: 30 Page(s): 340 - 342
  04/01/2009 Authors: Hill G; Castellino S; Williams D
• Risks of mortality in 5 year survivors of Hodgkin's Lymphoma (HL) in the Childhood Cancer Survivor Study (CCSS)
  JOURNAL OF CLINICAL ONCOLOGY Volume: 26
  05/20/2008 Authors: Castellino SM; Tooze J; Geiger AM; Leisenring WM; Goodman P; Mertens A; Stovall M; Robison LL; Hudson M
• Risks of mortality in 5 year survivors of Hodgkin's Lymphoma (HL) in the Childhood Cancer Survivor Study (CCSS).
  J Clin Oncol Volume: 26 Page(s): 10006
  05/20/2008 Authors: Castellino SM; Tooze J; Geiger AM; Leisenring WM; Goodman P; Mertens A; Stovall M; Robison LL; Hudson M
• Pediatric genitourinary tumors.
  Curr Opin Oncol Volume: 20 Page(s): 315 - 320
  05/01/2008 Authors: McLean TW; Castellino SM
• Effect of race on the outcome of pediatric patients with Hodgkin's lymphoma.
  J Clin Oncol Volume: 26 Page(s): 1282 - 1288
  03/10/2008 Authors: Metzger ML; Castellino SM; Hudson MM; Rai SN; Kaste SC; Krasin MJ; Kun LE; Pui C-H; Howard SC
• Outcomes in childhood AML in the absence of transplantation in first remission--Children's Cancer Group (CCG) studies 2891 and CCG 213.
  Pediatr Blood Cancer Volume: 50 Page(s): 9 - 16
  01/01/2008 Authors: Castellino SM; Alonzo TA; Buxton A; Gold S; Lange BJ; Woods WG
• Pediatric genitourinary tumors.
  Curr Opin Oncol Volume: 19 Page(s): 248 - 253
  05/01/2007 Authors: Castellino SM; McLean TW
• Minority adult survivors of childhood cancer: a comparison of long-term outcomes, health care utilization, and health-related behaviors from the childhood cancer survivor study.
  Volume: 23 Page(s): 6499 - 6507
  09/20/2005 Authors: Castellino SM; Casillas J; Hudson MM; Mertens AC; Whitton J; Brooks SL; Zeltzer LK; Ablin A; Castleberry R; Hobbie W
• The effect of insurance and ethnicity on healthcare access and health behaviors: A Childhood Cancer Survivor Study (CCSS).
  Volume: 23 Page(s): 113S - 113S
  06/01/2005 Authors: Casillas JN; Castellino SM; Hudson MM; Mertens AC; Whitton J; Brooks SL; Zeltzer LR; Ablin A; Robison LL; Oeffinger KC
• The effect of insurance and ethnicity on healthcare access and health behaviors: A Childhood Cancer Survivor Study (CCSS).
  J Clin Oncol Volume: 23 Page(s): 1028
  06/01/2005 Authors: Casillas JN; Castellino SM; Hudson MM; Mertens AC; Whitton J; Brooks SL; Zeltzer LK; Ablin A; Robison LL; Oeffinger KC
• Comparison of long-term outcomes, health care utilization, and health behaviors in young adult African American (AA) survivors of childhood cancerwith white, non-hispanic(WNH) survivors: A childhood cancer survivor study (CCSS)
  Volume: 55 Page(s): 302A - 302A
  04/01/2004 Authors: Castellino SM; Hudson MM; Mertens AC; Yeazel M; Whitton J; Brooks S; Ablin A; Castleberry RP; Hobbie WL; Kaste S
• The epidemiology of chronic hepatitis C infection in survivors of childhood cancer: an update of the St Jude Children's Research Hospital hepatitis C seropositive cohort.
  Blood Volume: 103 Page(s): 2460 - 2466
  04/01/2004 Authors: Castellino S; Lensing S; Riely C; Rai SN; Davila R; Hayden RT; Fleckenstein J; Levstik M; Taylor S; Dean PJ
• The natural history of transfusion acquired hepatitis C (HCV) in childhood cancer survivors: An update of the St. Jude Children's Research Hospital (SJCRH)HCV seropositive (plus) cohort.
  Volume: 38 Page(s): 201A - 201A
  10/01/2003 Authors: Castellino SM; Riely CA; Lensing S; Levstik M; Davila R; Fleckenstein J; Taylor S; Hudson M
• The epidemiology of chronic hepatitis C infection in survivors of childhood cancer - An update of the St. Jude Children's Research Hospital (SJCRH) hepatitis C seropositive cohort
  Volume: 53 Page(s): 268A - 268A
  04/01/2003 Authors: Castellino SM; Lensing S; Riely C; Hudson MM
• Health issues in survivors of childhood cancer.
  South Med J Volume: 95 Page(s): 977 - 984
  09/01/2002 Authors: Castellino S; Hudson MM
• Abdominal rhabdoid tumor presenting as fetal hydrops: a case report.
  J Pediatr Hematol Oncol Volume: 23 Page(s): 258 - 259
  05/01/2001 Authors: Castellino SM; Powers R; Kalwinsky D; DeVoe M
• Acute lymphoblastic leukemia in infancy: Improved outcome with unrelated placental cord blood (PCB) transplants.
  BLOOD Volume: 94 Page(s): 712A - 712A
  11/15/1999 Authors: Scaradavou A; Castellino S; Stevens C; Brochstein J; Wagner J; Kletzel M; Yu L; Rubinstein P; Kurtzberg J
• Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance.
  Br J Haematol Volume: 104 Page(s): 189 - 194
  01/01/1999 Authors: Castellino SM; Combs MR; Zimmerman SA; Issitt PD; Ware RE
• Retroviral vector-mediated gene transfer into umbilical cord blood-derived megakaryocyte and platelet progenitors.
  Biol Blood Marrow Transplant Volume: 5 Page(s): 215 - 221
  01/01/1999 Authors: Castellino SM; Kurtzberg J; Smith C
• Ewing's tumor and papillary adenocarcinoma of the thyroid in a 14-year-old girl.
  J Pediatr Hematol Oncol Volume: 20 Page(s): 177 - 180
  01/01/1998 Authors: Castellino S; Traweek T; Rosoff PM
• Serologic and clinical characteristics of erythrocyte autoantibodies in children receiving chronic transfusion therapy.
  Volume: 90 Page(s): 3287 - 3287
  11/15/1997 Authors: Castellino S; Combs MR; Kinney TR; Issitt PD; Ware RE
• Ex vivo expansion and retroviral vector transduction of umbilical cord food (UCB) platelet progenitors.
  Volume: 90 Page(s): 2392 - 2392
  11/15/1997 Authors: Castellino S; Kurtzberg J; Gentry T; Gilboa E; Smith C
• Multiparameter fluorescence activated cell sorting analysis of retroviral vector gene transfer into primitive umbilical cord blood cells.
  Volume: 88 Page(s): 1727 - 1727
  11/15/1996 Authors: Gentry T; McCowage GB; Phillips KL; Castellino S; Hull S; Kurtzberg J; Gilboa E; Smith C
• Relapsed acute lymphoblastic leukemia: similar outcomes for autologous and allogeneic marrow transplantation in selected children.
  Bone Marrow Transplant Volume: 17 Page(s): 763 - 768
  05/01/1996 Authors: Parsons SK; Castellino SM; Lehmann LE; Eickhoff CE; Tarbell NJ; Sallan SE; Weinstein HJ; Billett AL
• Flunarizine enhancement of melphalan activity against drug-sensitive/resistant rhabdomyosarcoma.
  Br J Cancer Volume: 71 Page(s): 1181 - 1187
  06/01/1995 Authors: Castellino SM; Friedman HS; Elion GB; Ong ET; Marcelli SL; Page R; Bigner DD; Dewhirst MW
• Development of a model of melphalan-induced gastrointestinal toxicity in mice.
  Cancer Chemother Pharmacol Volume: 31 Page(s): 376 - 380
  01/01/1993 Authors: Castellino S; Elion GB; Griffith OW; Dewhirst M; Kurtzberg J; Cattley RC; Scott P; Bigner DD; Friedman HS
• Neuropeptide Y (NPY) in human nasal mucosa.
  Am J Respir Cell Mol Biol Volume: 3 Page(s): 165 - 173
  08/01/1990 Authors: Baraniuk JN; Castellino S; Lundgren JD; Goff J; Mullol J; Merida M; Shelhamer JH; Kaliner MA